Does radiotherapy have a role in the management of thyroid orbitopathy? View 1
- PMID: 11801513
- PMCID: PMC1770958
Does radiotherapy have a role in the management of thyroid orbitopathy? View 1
Figures
Comment in
-
Does radiotherapy have a role in the management of thyroid orbitopathy? View 2.Br J Ophthalmol. 2002 Jan;86(1):104-6. Br J Ophthalmol. 2002. PMID: 11806399 Review. No abstract available.
-
Does radiotherapy have a role in the management of thyroid orbitopathy? Comment.Br J Ophthalmol. 2002 Jan;86(1):106-7. Br J Ophthalmol. 2002. PMID: 11806400 Review. No abstract available.
References
-
- Barsouk A, Peele KA, Kiljanski J, et al. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders. J Endocrin Invest 1996;19:334–41. - PubMed
-
- Wall JR, Barsouk A, Stolarski C, et al. Serum muscle antibodies predicted the development of ophthalmopathy in a euthyroid subject with a family history of autoimmunity. Thyroid 1996;6:353–8. - PubMed
-
- Peele-Cockerham KA, Kennerdell JS. Thyroid-associated orbitopathy. Focal Points 1997;XV(1): 1–14.
-
- Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983;56:1139–44. - PubMed
-
- Hurbli T, Char DH, Harris J, et al. Radiation therapy for thyroid eye diseases. Am J Ophthalmol 1985;99:633–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources